Ocugen Stock

Ocugen EBITDA

The EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Ocugen (OCGN) as of Aug 16, 2026 is -63.58 M USD. In the previous year, EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) was -54.76 M USD — a change of 16.11% (lower).

EBITDA

-63.58 MUSD

YoY

16.11%

Last updated:

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Ocugen is 2026 -63.58 M USD. EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Ocugen was 2025 -54.76 M USD. It decreases by 16.11% lower compared to the previous year.
Access this data via the Eulerpool API

Ocugen Stock analysis

What does Ocugen do? Ocugen Inc is a US-based biopharmaceutical company specializing in the development and commercialization of innovative therapeutics and vaccines. The company was founded in 2013 and is headquartered in Malvern, Pennsylvania. It has a strong pipeline of products in various stages of development, with a focus on treating eye diseases and other medical conditions. Ocugen has also entered into partnerships for the development and marketing of COVID-19 vaccines, including Covaxin. Overall, Ocugen Inc is expected to be a significant player in the biopharmaceutical industry in the coming years. Ocugen is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Ocugen stock

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Ocugen is -63.58 M USD in 2026.

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Ocugen changed from -54.76 M USD to -63.58 M USD, representing a 16.11% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) Ocugen since 2006 – with annual values, charts, and detailed analysis.

EBITDA measures operating performance before the impact of financial structure, tax environment, and non-cash depreciation charges.

EBITDA = EBIT + Depreciation & Amortization

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization)'s USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization)'s Ocugen historically and in real time.

Access this data via the Eulerpool API

Income Statement — Ocugen

All Key Metrics — Ocugen